3-methyl-5-[[(3S,4R)-4-(2-pyrazolo[1,5-a]pyridin-7-ylimidazol-1-yl)oxolan-3-yl]methyl]-1,2-oxazole
C19H19N5O2 — CID 154822887
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-methyl-5-[[(3S,4R)-4-(2-pyrazolo[1,5-a]pyridin-7-ylimidazol-1-yl)oxolan-3-yl]methyl]-1,2-oxazole
3-methyl-5-[[(3S,4R)-4-(2-pyrazolo[1,5-a]pyridin-7-ylimidazol-1-yl)oxolan-3-yl]methyl]-1,2-oxazole (PubChem CID 154822887) has the molecular formula C19H19N5O2 and a molecular weight of 349.39 g/mol. Its IUPAC name is 3-methyl-5-[[(3S,4R)-4-(2-pyrazolo[1,5-a]pyridin-7-ylimidazol-1-yl)oxolan-3-yl]methyl]-1,2-oxazole.
Molecular Properties
| Compound Name | 3-methyl-5-[[(3S,4R)-4-(2-pyrazolo[1,5-a]pyridin-7-ylimidazol-1-yl)oxolan-3-yl]methyl]-1,2-oxazole |
|---|---|
| PubChem CID | 154822887 |
| Molecular Formula | C19H19N5O2 |
| Molecular Weight | 349.39 g/mol |
| Exact Mass | 349.15 |
| IUPAC Name | 3-methyl-5-[[(3S,4R)-4-(2-pyrazolo[1,5-a]pyridin-7-ylimidazol-1-yl)oxolan-3-yl]methyl]-1,2-oxazole |
| SMILES | Cc1cc(C[C@@H]2COC[C@@H]2n2ccnc2-c2cccc3ccnn23)on1 |
| InChI | InChI=1S/C19H19N5O2/c1-13-9-16(26-22-13)10-14-11-25-12-18(14)23-8-7-20-19(23)17-4-2-3-15-5-6-21-24(15)17/h2-9,14,18H,10-12H2,1H3/t14-,18+/m1/s1 |
| InChIKey | CUIUPZBCAMKQNT-KDOFPFPSSA-N |
| XLogP | 2.92 |
| TPSA | 70.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 349.39 |
| LogP ≤ 5 | 2.92 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154822887 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.